癌症与动脉粥样硬化中的免疫。
Immunity in cancer and atherosclerosis.
作者信息
Sima Petr, Vannucci Luca, Vetvicka Vaclav
机构信息
Laboratory of Immunotherapy, Institute of Microbiology, Academy of Sciences, Prague, Czech Republic.
Department of Pathology, University of Louisville, Louisville, KY, USA.
出版信息
Ann Transl Med. 2019 May;7(9):204. doi: 10.21037/atm.2019.04.56.
Abstract
Cancer and cardiovascular diseases have been classified as non-communicable diseases for decades. Both diseases have characteristics of immune reactions, which are principally identical, but differing in important aspects. The aim of this communication is to highlight new approaches to immune processes involved in both types of diseases.
摘要
几十年来，癌症和心血管疾病都被归类为非传染性疾病。这两种疾病都具有免疫反应特征，它们在本质上是相同的，但在重要方面存在差异。本交流的目的是强调涉及这两种疾病的免疫过程的新方法。
相似文献
1
Immunity in cancer and atherosclerosis.
Ann Transl Med. 2019 May;7(9):204. doi: 10.21037/atm.2019.04.56.
2
Trained Innate Immunity as a Novel Mechanism Linking Infection and the Development of Atherosclerosis.
Circ Res. 2018 Mar 2;122(5):664-669. doi: 10.1161/CIRCRESAHA.117.312465. Epub 2018 Jan 24.
3
Danger signaling in atherosclerosis.
Circ Res. 2015 Jan 16;116(2):323-40. doi: 10.1161/CIRCRESAHA.116.301135.
4
Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
Curr Pharm Des. 2019;25(29):3128-3146. doi: 10.2174/1381612825666190830164917.
5
Infections, immunity and atherosclerosis: pathogenic mechanisms and unsolved questions.
Int J Cardiol. 2013 Jul 1;166(3):572-83. doi: 10.1016/j.ijcard.2012.05.098. Epub 2012 Jun 22.
6
[Dendritic cells and their role in immune reactions of atherosclerosis].
Tsitologiia. 2012;54(11):793-805.
7
Immunosurveillance and cancer: epidemiologic observations.
Natl Cancer Inst Monogr. 1977 Dec;47:121-6.
8
T cells, immunosurveillance, and cutaneous immunity.
J Dermatol Sci. 2000 Dec;24 Suppl 1:S41-5. doi: 10.1016/s0923-1811(00)00140-7.
9
MicroRNAs and atherosclerosis: new actors for an old movie.
Nutr Metab Cardiovasc Dis. 2012 Nov;22(11):937-43. doi: 10.1016/j.numecd.2012.03.007. Epub 2012 Jun 28.
10
Long-term activation of the innate immune system in atherosclerosis.
Semin Immunol. 2016 Aug;28(4):384-93. doi: 10.1016/j.smim.2016.04.004. Epub 2016 Apr 22.
引用本文的文献
1
Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors.
PLoS One. 2023 Nov 20;18(11):e0294438. doi: 10.1371/journal.pone.0294438. eCollection 2023.
2
A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma.
Sci Rep. 2023 Nov 2;13(1):18922. doi: 10.1038/s41598-023-45966-8.
3
Identification and verification of novel immune-related ferroptosis signature with excellent prognostic predictive and clinical guidance value in hepatocellular carcinoma.
Front Genet. 2023 Aug 21;14:1112744. doi: 10.3389/fgene.2023.1112744. eCollection 2023.
4
Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment.
Am J Transl Res. 2022 Sep 15;14(9):5982-6010. eCollection 2022.
5
CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma.
Oxid Med Cell Longev. 2022 Sep 19;2022:8421813. doi: 10.1155/2022/8421813. eCollection 2022.
6
Persistent DNA damage and oncogenic stress-induced Trem1 promotes leukemia in mice.
Haematologica. 2022 Nov 1;107(11):2576-2588. doi: 10.3324/haematol.2021.280404.
7
Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
BMC Cancer. 2022 Mar 25;22(1):325. doi: 10.1186/s12885-022-09402-w.
8
A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.
Bioengineered. 2021 Dec;12(1):4259-4277. doi: 10.1080/21655979.2021.1955558.
9
Bioinformatics Analyses Indicate That Cathepsin G (CTSG) is a Potential Immune-Related Biomarker in Oral Squamous Cell Carcinoma (OSCC).
Onco Targets Ther. 2021 Feb 25;14:1275-1289. doi: 10.2147/OTT.S293148. eCollection 2021.
10
Inflammatory Markers Related to Innate and Adaptive Immunity in Atherosclerosis: Implications for Disease Prediction and Prospective Therapeutics.
J Inflamm Res. 2021 Feb 16;14:379-392. doi: 10.2147/JIR.S294809. eCollection 2021.
本文引用的文献
1
Atherosclerosis as autoimmune disease.
Ann Transl Med. 2018 Apr;6(7):116. doi: 10.21037/atm.2018.02.02.
2
Adventitial tertiary lymphoid organ classification in human atherosclerosis.
Cardiovasc Pathol. 2018 Jan-Feb;32:8-14. doi: 10.1016/j.carpath.2017.08.002. Epub 2017 Sep 7.
3
'Trained immunity': consequences for lymphoid malignancies.
Haematologica. 2016 Dec;101(12):1460-1468. doi: 10.3324/haematol.2016.149252. Epub 2016 Nov 10.
4
Artery Tertiary Lymphoid Organs: Powerhouses of Atherosclerosis Immunity.
Front Immunol. 2016 Oct 10;7:387. doi: 10.3389/fimmu.2016.00387. eCollection 2016.
5
Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype.
Int J Cancer. 2016 Jan 15;138(2):271-80. doi: 10.1002/ijc.29375. Epub 2014 Dec 13.
6
Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes.
Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1731-8. doi: 10.1161/ATVBAHA.114.303887. Epub 2014 Jun 5.
7
Trained innate immunity and atherosclerosis.
Curr Opin Lipidol. 2013 Dec;24(6):487-92. doi: 10.1097/MOL.0000000000000023.
8
Local proliferation dominates lesional macrophage accumulation in atherosclerosis.
Nat Med. 2013 Sep;19(9):1166-72. doi: 10.1038/nm.3258. Epub 2013 Aug 11.
9
The tumor microenvironment at a glance.
J Cell Sci. 2012 Dec 1;125(Pt 23):5591-6. doi: 10.1242/jcs.116392.
10
Molecular mechanisms and clinical applications of angiogenesis.
Nature. 2011 May 19;473(7347):298-307. doi: 10.1038/nature10144.
Zotero 插件